Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety

OBJECTIVE: For patients with advanced or metastatic renal cell carcinoma (RCC), the dose of targeted agents was recommended in combination with immune checkpoint inhibitors. We performed a network meta‐analysis to describe a categorized safety ranking profile and assess the adaptability of the combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Bi, Xingang, Jiang, Weixing, Cao, Chuanzhen, Zhou, Aiping, Shi, Hongzhe, Shou, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067120/
https://www.ncbi.nlm.nih.gov/pubmed/36457303
http://dx.doi.org/10.1002/cam4.5504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067120/
https://www.ncbi.nlm.nih.gov/pubmed/36457303
http://dx.doi.org/10.1002/cam4.5504

Ejemplares similares